NICE widens view of Sutent in GIST
This article was originally published in Scrip
Executive Summary
Gastrointestinal stromal tumour (GIST) patients in the national health service in England and Wales may have the option of being treated with Pfizer's Sutent (sunitinib) in specific circumstances.